How much did Juno sell for

On January 22, 2018, Juno Therapeutics was acquired by biotechnology company Celgene for $9 billion.

Who bought Juno?

Gett made a significant move to consolidate its position in the U.S. — specifically the key New York market where it operated — when it acquired Juno, a smaller rival in the New York market, for about $250 million in 2017.

Who founded Juno Therapeutics?

Larry Corey, MD, co-founder of Juno Therapeutics, may soon launch another drug company, according to STAT. Celgene acquired Juno Therapeutics for $9 billion in 2018.

When did Juno Therapeutics go public?

The biotech was an early pioneer in cancer cell therapy and splashed onto the public markets in 2014 with a $265 million IPO, touting an array of treatments in early testing. From an investor perspective, Juno succeeded.

Where is Juno Therapeutics located?

Company Description: Juno Therapeutics, Inc. is located in Seattle, WA, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry.

Why did Juno shut down?

Gett said in a statement that Juno is shutting down “as a result of both Gett’s increased focus on the corporate transportation sector and the enactment of misguided regulations in New York City earlier this year.” … Gett said drivers will be paid in full for all rides completed by Juno’s service end-date.

Did LYFT buy Juno?

IndustryVehicle for hireSuccessorLyftHeadquartersNew York City, New YorkNumber of employees273ParentGett (2017-2019)

What company owns Celgene?

Deal of the Year: Bristol-Myers Squibb buys Celgene. By erasing one of the industry’s most active partners, the $74 billion deal promises to shake up biotech for years to come.

When did Celgene buy Juno?

A few months later, in January 2018, Celgene acquired Juno in a $9 billion deal. The New Jersey-based biotech company continues to operate Juno’s Seattle R&D space and its manufacturing facility in nearby Bothell, Wash. Giovanni Caforio, Bristol-Myers Squibb CEO.

When did ShockWave go public?

(“ShockWave”) today announced the pricing of its initial public offering of 5,700,000 shares of its common stock at a price to the public of $17.00 per share. The shares are expected to begin trading on the Nasdaq Global Select Market on March 7, 2019, under the symbol “SWAV”.

Article first time published on

Why is it called Juno?

Named in tribute to Pierre Juneau, the first chairperson of the Canadian Radio-television and Telecommunications Commission (CRTC), the JUNO Awards were founded to raise the public profile and recognition of musical artists in Canada.

Who bought Neon Therapeutics?

MAINZ, Germany and CAMBRIDGE, Mass., May 06, 2020 (GLOBE NEWSWIRE) — BioNTech (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today the closing of the Neon Therapeutics, Inc. (Nasdaq: NTGN, “Neon”) acquisition through an all-stock transaction.

Where is PTC Therapeutics located?

PTC Therapeutics – Gene Therapy Manufacturing in Hopewell, New Jersey.

Where is Acorda Therapeutics located?

Acorda Therapeutics, Inc. 420 Saw Mill River Road, Ardsley, New York, U.S. Acorda Therapeutics, Inc. is an American biotechnology company based in Ardsley, New York.

Where is Abeona Therapeutics located?

TypePublicHQDallas, TX, USMapWebsiteabeonatherapeutics.comEmployee Ratings3.8MoreOverall CultureA+More

Why did Lyft charge me $1?

What’s a temporary authorization? Temporary authorizations are used to confirm that your payment method works and has enough funds to cover ride costs. Authorizations appear as ‘pending’ transactions in your bank account, but they aren’t charges.

Why is Lyft suddenly so expensive?

Uber and Lyft rides are more expensive than ever because of a driver shortage. The cost of a ride from a ride-sharing app like Uber or Lyft increased 92% between January 2018 and July 2021, according to Rakuten Intelligence. … The main reason is a shortage of drivers.

Who owns most of Lyft?

StockholderStakeShares ownedFidelity Management & Research Co...13.66%45,354,145The Vanguard Group, Inc.7.18%23,842,017JPMorgan Investment Management, I…4.41%14,648,986BlackRock Fund Advisors3.47%11,527,783

Is Gett in the US?

Gett is expanding its reach in the U.S. and Canada through the launch of a new, strategic partnership with Lyft – the popular ride-hailing firm based in San Francisco that operates throughout North America – in 644 cities in the United States and 12 cities in Canada.

What is ZIRO Rideshare?

ZIRO is the first socially responsible ride-sharing company dedicated to treating drivers fairly, charging riders less, and preserving the planet. With ZIRO, drivers keep 100% of what they earn and riders save 25% of what they spend.

What is the issue in Juno?

Juno, is about a 16-year-old, high school girl faced with the challenge of an unplanned pregnancy. As she sits in an abortion clinic waiting to abort her unborn child, she decides to have the baby. She is aware that she can’t raise it herself and decides to give her child up for adoption.

Did Celgene get bought out?

NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has completed its acquisition of Celgene Corporation (NASDAQ:CELG) following the receipt of regulatory approval from all government authorities required by the merger agreement and, as announced on April 12, 2019, approval by …

What happens to Celgene stock after merger?

Approximately 80 percent of the shares to be repurchased under the transaction will be received by Bristol-Myers Squibb on November 27, 2019. … Bristol-Myers Squibb anticipates that all repurchases under the ASR will be completed by the end of the second quarter of 2020.

When did Celgene buy Abraxis?

SUMMIT, N.J., Oct 15, 2010 (BUSINESS WIRE) — Celgene Corporation (NASDAQ: CELG) today announced it has completed its acquisition of Abraxis BioScience, Inc.

Who bought out Bristol-Myers Squibb?

Jones Day advised Celgene Corporation (NASDAQ: CELG) in connection with the intellectual property and technology transactions aspects of its cash-and-stock merger with Bristol-Myers Squibb (NYSE: BMY) which has an equity value of approximately $74 billion.

What company did Bristol Myers buy?

Bristol Myers Squibb acquires Medarex, Inc., a biotech company and a partner since 2005. The acquisition significantly expands the company’s oncology and immunology pipeline.

Who did Bristol Myers buy?

When Bristol Myers Squibb bought the biotech Celgene for $80 billion in late 2019, it tacked on a sweetener: If three experimental Celgene treatments received Food and Drug Administration approval on time, Bristol would pay an extra $9 a share, for a total of over $6 billion.

Is Shockwave a good stock to buy?

Valuation metrics show that ShockWave Medical, Inc. may be overvalued. Its Value Score of D indicates it would be a bad pick for value investors. The financial health and growth prospects of SWAV, demonstrate its potential to underperform the market.

Who founded Shockwave medical?

Todd Brinton co-founded Shockwave Medical in 2009 after completing the Biodesign Innovation Fellowship in 2005. To learn more about the technology, visit the Shockwave Medical website.

When did BIGC go public?

The shares are expected to begin trading on the Nasdaq Global Market on August 5, 2020 under the ticker symbol “BIGC,” and the offering is expected to close on August 7, 2020, subject to customary closing conditions.

How old is Juno?

JUNO’s 16-year-old protagonist, Juno MacGuff (Elliot Page), is a handful: She’s mouthy and opinionated, disdains authority, thinks she knows everything, pops ADD drug Adderall, and has casual sex. And if she has to take on pregnancy to complete her journey into adulthood, then so be it.